- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 30.5 | -5.43 | -15.93 | 1.62 | 17.39 | 21.8 | 1.25 | 5.93 | 27.55 | 0 | 0 | 0 | 5.31 | 24.13 | 44.89 | 4.10 | 12.01 | 51.72 | 0.00 | 0 | 0 | 0 | 0 | 0 |
24Q2 (19) | 32.25 | 6.47 | -11.38 | 1.38 | 4.55 | -4.83 | 1.18 | 18.0 | 42.17 | 0 | 0 | 0 | 4.28 | -1.81 | 7.39 | 3.66 | 10.83 | 60.42 | 0.00 | 0 | 0 | 0 | 0 | 0 |
24Q1 (18) | 30.29 | -21.24 | -19.51 | 1.32 | -16.98 | -14.29 | 1.0 | 7.53 | 19.05 | 0 | 0 | 0 | 4.36 | 5.41 | 6.48 | 3.30 | 36.53 | 47.9 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q4 (17) | 38.46 | 6.01 | -12.59 | 1.59 | 19.55 | -13.11 | 0.93 | -5.1 | 6.9 | 0 | 0 | 0 | 4.13 | 12.77 | -0.6 | 2.42 | -10.48 | 22.29 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q3 (16) | 36.28 | -0.3 | -13.7 | 1.33 | -8.28 | -23.12 | 0.98 | 18.07 | 13.95 | 0 | 0 | 0 | 3.67 | -8.0 | -10.92 | 2.70 | 18.43 | 32.05 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q2 (15) | 36.39 | -3.3 | -10.15 | 1.45 | -5.84 | -8.23 | 0.83 | -1.19 | 0.0 | 0 | 0 | 0 | 3.98 | -2.64 | 2.14 | 2.28 | 2.18 | 11.29 | 0.00 | 0 | 0 | 0 | 0 | 0 |
23Q1 (14) | 37.63 | -14.48 | 0.67 | 1.54 | -15.85 | 2.67 | 0.84 | -3.45 | 18.31 | 0 | 0 | 0 | 4.09 | -1.6 | 1.98 | 2.23 | 12.9 | 17.52 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q4 (13) | 44.0 | 4.66 | 38.41 | 1.83 | 5.78 | 8.28 | 0.87 | 1.16 | 6.1 | 0 | 0 | 0 | 4.16 | 1.07 | -21.76 | 1.98 | -3.34 | -23.34 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q3 (12) | 42.04 | 3.8 | 32.37 | 1.73 | 9.49 | 66.35 | 0.86 | 3.61 | 26.47 | 0 | 0 | 0 | 4.12 | 5.48 | 25.67 | 2.05 | -0.18 | -4.46 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q2 (11) | 40.5 | 8.35 | 41.76 | 1.58 | 5.33 | 75.56 | 0.83 | 16.9 | 36.07 | 0 | 0 | 0 | 3.90 | -2.78 | 23.84 | 2.05 | 7.9 | -4.01 | 0.00 | 0 | 0 | 0 | 0 | 0 |
22Q1 (10) | 37.38 | 17.58 | 26.54 | 1.5 | -11.24 | 50.0 | 0.71 | -13.41 | 12.7 | 0 | 0 | 0 | 4.01 | -24.52 | 18.54 | 1.90 | -26.36 | -10.94 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q4 (9) | 31.79 | 0.09 | 7.65 | 1.69 | 62.5 | 128.38 | 0.82 | 20.59 | 51.85 | 0 | 0 | 0 | 5.32 | 62.35 | 112.14 | 2.58 | 20.47 | 41.06 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q3 (8) | 31.76 | 11.17 | 7.41 | 1.04 | 15.56 | 11.83 | 0.68 | 11.48 | 15.25 | 0 | 0 | 0 | 3.27 | 3.95 | 4.12 | 2.14 | 0.28 | 7.31 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q2 (7) | 28.57 | -3.28 | -7.66 | 0.9 | -10.0 | -7.22 | 0.61 | -3.17 | 0.0 | 0 | 0 | 0 | 3.15 | -6.94 | 0.48 | 2.14 | 0.11 | 8.3 | 0.00 | 0 | 0 | 0 | 0 | 0 |
21Q1 (6) | 29.54 | 0.03 | 0.75 | 1.0 | 35.14 | 20.48 | 0.63 | 16.67 | 16.67 | 0 | 0 | 0 | 3.39 | 35.09 | 19.58 | 2.13 | 16.63 | 15.8 | 0.00 | 0 | 0 | 0 | 0 | 0 |
20Q4 (5) | 29.53 | -0.14 | 7.93 | 0.74 | -20.43 | -28.85 | 0.54 | -8.47 | 1.89 | 0 | 0 | 0 | 2.51 | -20.32 | -34.07 | 1.83 | -8.35 | -5.6 | 0.00 | 0 | 0 | 0 | 0 | 0 |
20Q3 (4) | 29.57 | -4.43 | 0.0 | 0.93 | -4.12 | 0.0 | 0.59 | -3.28 | 0.0 | 0 | 0 | 0.0 | 3.15 | 0.32 | 0.0 | 2.00 | 1.2 | 0.0 | 0.00 | 0 | 0.0 | 0 | 0 | 0.0 |
20Q2 (3) | 30.94 | 5.53 | 0.0 | 0.97 | 16.87 | 0.0 | 0.61 | 12.96 | 0.0 | 0 | 0 | 0.0 | 3.14 | 10.75 | 0.0 | 1.97 | 7.05 | 0.0 | 0.00 | 0 | 0.0 | 0 | 0 | 0.0 |
20Q1 (2) | 29.32 | 7.16 | 0.0 | 0.83 | -20.19 | 0.0 | 0.54 | 1.89 | 0.0 | 0 | 0 | 0.0 | 2.83 | -25.53 | 0.0 | 1.84 | -4.92 | 0.0 | 0.00 | 0 | 0.0 | 0 | 0 | 0.0 |
19Q4 (1) | 27.36 | 0.0 | 0.0 | 1.04 | 0.0 | 0.0 | 0.53 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 3.80 | 0.0 | 0.0 | 1.94 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 148.76 | -9.25 | 5.91 | -10.99 | 3.58 | 9.48 | 0 | 0 | 3.97 | -1.92 | 2.41 | 20.64 | 0.00 | 0 | 0 | 0 |
2022 (9) | 163.93 | 34.74 | 6.64 | 43.41 | 3.27 | 19.34 | 0 | 0 | 4.05 | 6.43 | 1.99 | -11.43 | 0.00 | 0 | 0 | 0 |
2021 (8) | 121.66 | 1.94 | 4.63 | 33.05 | 2.74 | 20.18 | 0 | 0 | 3.81 | 30.52 | 2.25 | 17.89 | 0.00 | 0 | 0 | 0 |
2020 (7) | 119.35 | 2.57 | 3.48 | -16.35 | 2.28 | 3.17 | 0 | 0 | 2.92 | -18.44 | 1.91 | 0.58 | 0.00 | 0 | 0 | 0 |
2019 (6) | 116.36 | -28.87 | 4.16 | -24.64 | 2.21 | -4.74 | 0 | 0 | 3.58 | 5.95 | 1.90 | 33.92 | 0.00 | 0 | 0 | 0 |
2018 (5) | 163.58 | 28.67 | 5.52 | 31.43 | 2.32 | 3.11 | 0 | 0 | 3.37 | 2.14 | 1.42 | -19.86 | 0.00 | 0 | 1023 | 0.0 |
2017 (4) | 127.13 | 17.78 | 4.2 | 111.06 | 2.25 | 10.29 | 0 | 0 | 3.30 | 79.2 | 1.77 | -6.35 | 0.00 | 0 | 1023 | 0.0 |
2016 (3) | 107.94 | 2.92 | 1.99 | -1.0 | 2.04 | 10.87 | 0 | 0 | 1.84 | -3.8 | 1.89 | 7.73 | 0.00 | 0 | 1023 | 0.0 |
2015 (2) | 104.88 | -5.91 | 2.01 | 28.85 | 1.84 | 9.52 | 0 | 0 | 1.92 | 36.94 | 1.75 | 16.41 | 0.00 | 0 | 1023 | 0.0 |
2014 (1) | 111.47 | 13.02 | 1.56 | 26.83 | 1.68 | 5.0 | 0 | 0 | 1.40 | 0 | 1.51 | 0 | 0.00 | 0 | 1023 | 0.0 |